ID
42054
Description
Study documentation part: Other diseases and therapies except tumors, VTETumor02. This is a prospective, randomized, controlled, unicentric, open study on prophylactic treatment of thromboembolism with Enoxaparin in non-surgical oncology patients under systemic antineoplastic therapy. Principal Investigator Prof. Dr. Max E. Scheulen, Clinic and Polyclinic for Internal medicine (Tumor research), University Hospital of Essen, Germany. EudraCT number: 2007-002036-28, Version 0.6 vom 06.08.09.
Keywords
Versions (2)
- 9/21/16 9/21/16 -
- 3/15/21 3/15/21 - Dr. rer. medic Philipp Neuhaus
Uploaded on
March 15, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
End form: Other diseases and therapies except tumors VTETumor02 Prophylactic Treatment of Thromboembolism with Enoxaparin EudraCT number: 2007-002036-28
Other diseases and therapies except tumors
- StudyEvent: ODM
Similar models
Other diseases and therapies except tumors
- StudyEvent: ODM
C0087111 (UMLS CUI-3)
C0035648 (UMLS CUI [2])
C0277793 (UMLS CUI [1,2])
C1299555 (UMLS CUI [1,2])
C0870450 (UMLS CUI [1,2])
C3665894 (UMLS CUI [1,2])